BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12572865)

  • 1. Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.
    Okazaki K; Nakase H; Watanabe N; Tabata Y; Ikada Y; Chiba T
    J Gastroenterol; 2002 Nov; 37 Suppl 14():44-52. PubMed ID: 12572865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Matsushima Y; Kawanami C; Oshima C; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):15-21. PubMed ID: 10604927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice.
    Watanabe N; Ikuta K; Okazaki K; Nakase H; Tabata Y; Matsuura M; Tamaki H; Kawanami C; Honjo T; Chiba T
    Dig Dis Sci; 2003 Feb; 48(2):408-14. PubMed ID: 12643623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
    Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
    Kwon KH; Murakami A; Tanaka T; Ohigashi H
    Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.
    Komiyama Y; Andoh A; Fujiwara D; Ohmae H; Araki Y; Fujiyama Y; Mitsuyama K; Kanauchi O
    Scand J Gastroenterol; 2011 Jan; 46(1):40-52. PubMed ID: 20735154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yogurt starter cultures of Streptococcus thermophilus and Lactobacillus bulgaricus ameliorate symptoms and modulate the immune response in a mouse model of dextran sulfate sodium-induced colitis.
    Wasilewska E; Zlotkowska D; Wroblewska B
    J Dairy Sci; 2019 Jan; 102(1):37-53. PubMed ID: 30343915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effective therapy of cyclosporine A with drug delivery system in experimental colitis.
    Fukata N; Uchida K; Kusuda T; Koyabu M; Miyoshi H; Fukui T; Matsushita M; Nishio A; Tabata Y; Okazaki K
    J Drug Target; 2011 Jul; 19(6):458-67. PubMed ID: 20804404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal T cells as a target for treatment of IBD.
    Watanabe M; Yamazaki M; Kanai T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():48-50. PubMed ID: 12698871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.
    Borrelli F; Fasolino I; Romano B; Capasso R; Maiello F; Coppola D; Orlando P; Battista G; Pagano E; Di Marzo V; Izzo AA
    Biochem Pharmacol; 2013 May; 85(9):1306-16. PubMed ID: 23415610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.
    Bhavsar MD; Amiji MM
    Gene Ther; 2008 Sep; 15(17):1200-9. PubMed ID: 18418416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit.
    Wang B; Zhuang X; Deng ZB; Jiang H; Mu J; Wang Q; Xiang X; Guo H; Zhang L; Dryden G; Yan J; Miller D; Zhang HG
    Mol Ther; 2014 Mar; 22(3):522-534. PubMed ID: 23939022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J; Zheng C; Huang Y; Liang Y
    Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.
    Zhang S; Ermann J; Succi MD; Zhou A; Hamilton MJ; Cao B; Korzenik JR; Glickman JN; Vemula PK; Glimcher LH; Traverso G; Langer R; Karp JM
    Sci Transl Med; 2015 Aug; 7(300):300ra128. PubMed ID: 26268315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-19 protects mice from innate-mediated colonic inflammation.
    Azuma YT; Matsuo Y; Kuwamura M; Yancopoulos GD; Valenzuela DM; Murphy AJ; Nakajima H; Karow M; Takeuchi T
    Inflamm Bowel Dis; 2010 Jun; 16(6):1017-28. PubMed ID: 19834971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.